Our website uses cookies to make navigation as functional as possible and to perform statistics on its usage. Should you wish to receive more information, or deny your consent to all or some of the cookies, please click here. By continuing to browse this website, you will be accepting our cookies.

A history of quality: the milestones

1886

The “Farmacia Internazionale Menarini” opens in Naples

1915

Menarini opens its Florence premises.

1964

Alberto Aleotti is appointed Director General of “Farmaceutica Menarini” and Internationalisation is launched with “Laboratorios Menarini” in Barcelona.

1978

Opening of Menarini Research&Development Division.

Since the 90s

Menarini has expanded its international business rapidly.

1992

Acquisition of Berlin-Chemie which opens up Central-East Europe markets to Menarini.

2003

Opening of Menarini Biotech in Pomezia (Rome).

2009

Lucia e Alberto Giovanni Aleotti leading Menarini.

2011

Acquisition of the Invida Group consolidating Menarini's presence in the Asia Pacific markets.

2013

Acquisition of Silicon Biosystems.

2016

VaxYnethic, a joint venture between Menarini and NewTech Biosynth in vaccines.

CellSearch, pioneer in advanced technologies for cancer diagnostics

2018

Dr Eric Cornut was appointed as new Chairman of the Menarini Group

View the photos or browse the special edition of "Menarini Informa" dedicated to our 125th anniversary

MENARINI PHARMA: ITALY – BENELUX - WORLD

Menarini was established more than 125 years ago (1886) in a small laboratory in Naples, Italy. In 1915, the laboratories were transferred to Florence, where the Menarini head office is still located.
From the 1960s, Menarini already understood the importance of expanding its horizons beyond national borders. Actually, the plant of Laboratorios Menarini in Barcelona dates from this period. When Dr. Alberto Aleotti was appointed to the head of Menarini in 1964, it had 188 employees and ranked 352nd in the ranking of European pharmaceutical companies. The 1970s were characterized by the strengthening of Menarini's position in Italy. This could be consolidated in the following decade thanks to numerous agreements with other important Italian pharmaceutical companies. It is under the aegis of Dr. Aleotti that Menarini has succeeded in developing his various strategies. Dr. Aleotti passed away in 2014. His daughter Lucia and his son Alberto Giovanni took then over as President and Vice President of the Menarini Group. The Menarini Group, led by the Aleotti family, decided in March 2018 to entrust as early as June the Chaimanship of the company to an external manager coming from another large multinational, Dr. Eric Cornut.

MENARINI PHARMA IN BENELUX: A story of more than 30 years


The eighties can be seen as a turning point in the international investment policy of the Menarini Group which was called the ‘Toscan Flower’ at that time.
Stimulated by Dr. Aleotti, the elaboration of the investment plan of Menarini started in 1983, in the capital of Europe, through the creation of the subsidiary Menarini Benelux in Brussels. At that time it was only the second subsidiary after Spain.
The development of the pharmaceutical activities of Menarini Benelux N.V./S.A. started in September 1987. At that time, the pharma team consisted of 15 employees including 9 medical representatives. We are now about 160 employees in Belgium and 20 in the Netherlands.
The activities of Menarini Benelux are focused on several markets: cardiology, allergy, gastroenterology, rheumatology, diabetology and pediatry.
Our company has been awarded many times, the ‘Gazellen Prize‘, organized by the economic magazine TRENDS which rewards the best performing companies in the Flemish region. We are really proud to belong to this select club which includes also large companies such as Microsoft, Novartis and Toyota. 

A history of quality:
the milestones

1886

The “Farmacia Internazionale Menarini” opens in Naples

1915

Menarini opens its Florence premises.

1964

Alberto Aleotti is appointed Director General of “Farmaceutica Menarini” and Internationalization is launched with “Laboratorios Menarini” in Barcelona.

1978

Opening of Menarini Research&Development Division.

Since the 90s

Menarini has expanded its international business rapidly.

1992

Acquisition of Berlin-Chemie which opens up Central-East Europe markets to Menarini.

2003

Opening of Menarini Biotech in Pomezia (Rome).

2009

Lucia and Alberto Giovanni Aleotti leading Menarini.

2011

Acquisition of the Invida Group consolidating Menarini's presence in the Asia Pacific markets.

2013

Acquisition of Silicon Biosystems.

2016

VaxYnethic, a joint venture between Menarini and NewTech Biosynth specialized in vaccines.

CellSearch, pioneer in advanced technologies for cancer diagnostics

2018

Dr Eric Cornut was appointed as new Chairman of the Menarini Group

OUR VALUES

10 core values which originated our group's success. READ MORE »

DIVISION DIAGNOSTICS

Advanced technology. READ MORE »

QUALITY FIRST

Quality: starting point and endpoint criteria for our medicines. READ MORE »

MENARINI IN THE WORLD

The Menarini Group has companies located almost all over the world. READ MORE »
Scroll Top